Literature DB >> 18493277

Endothelin and its potential role in glaucoma.

Balwantray C Chauhan1.   

Abstract

Endothelin is a potent vasoactive peptide occurring in 3 isotypes, ET-1, ET-2, and ET-3. Through its two main receptors, endothelin A and endothelin B, it is responsible for a variety of physiological functions, primarily blood flow control. Recent evidence from both human and experimental optic neuropathies shows involvement of endothelin and upregulation of its receptors (principally endothelin B). Experimental studies have shown that chronic ET-1 administration to the optic nerve immediately behind the globe causes neuronal damage, activation of astrocytes, the major glial cell in the anterior optic nerve, and upregulation of endothelin B receptors. This review outlines the ubiquitous role of endothelin and its potential involvement in glaucoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18493277     DOI: 10.3129/i08-060

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  26 in total

Review 1.  Intrinsic axonal degeneration pathways are critical for glaucomatous damage.

Authors:  Gareth R Howell; Ileana Soto; Richard T Libby; Simon W M John
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

Review 2.  Endothelin receptors: what's new and what do we need to know?

Authors:  Stephanie W Watts
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-11       Impact factor: 3.619

Review 3.  Management of Blood Pressure in Patients with Glaucoma.

Authors:  Russell M Levine; Alina Yang; Venkatesh Brahma; James F Martone
Journal:  Curr Cardiol Rep       Date:  2017-09-19       Impact factor: 2.931

Review 4.  Endothelin-1 gene regulation.

Authors:  Lisa R Stow; Mollie E Jacobs; Charles S Wingo; Brian D Cain
Journal:  FASEB J       Date:  2010-09-13       Impact factor: 5.191

5.  Effects of endothelin-1 on the cytoskeleton protein F-actin of human trabecular meshwork cells in vitro.

Authors:  Yan Xiang; Bin Li; Gui-Gang Li; Rui-Lin Wang; Zhi-Qi Chen; Ling-Juan Xu; Lan Chen; Hui Shi; Hong Zhang
Journal:  Int J Ophthalmol       Date:  2010-03-18       Impact factor: 1.779

6.  Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma.

Authors:  Gareth R Howell; Katharine H MacNicoll; Catherine E Braine; Ileana Soto; Danilo G Macalinao; Gregory L Sousa; Simon W M John
Journal:  Neurobiol Dis       Date:  2014-08-15       Impact factor: 5.996

Review 7.  Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities.

Authors:  Kimberly A Fernandes; Jeffrey M Harder; Pete A Williams; Rebecca L Rausch; Amy E Kiernan; K Saidas Nair; Michael G Anderson; Simon W M John; Gareth R Howell; Richard T Libby
Journal:  Exp Eye Res       Date:  2015-06-24       Impact factor: 3.467

8.  Aqueous humor rapidly stimulates myocilin secretion from human trabecular meshwork cells.

Authors:  Zachary T Resch; Cheryl R Hann; Kimberly A Cook; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2010-10-07       Impact factor: 3.467

Review 9.  [Vasculat treatment concepts in glaucoma patients].

Authors:  Karin R Pillunat; Lutz E Pillunat
Journal:  Ophthalmologe       Date:  2021-05       Impact factor: 1.059

10.  Endothelin-1 levels and biomarkers of oxidative stress in glaucoma patients.

Authors:  N López-Riquelme; C Villalba; C Tormo; A Belmonte; C Fernandez; G Torralba; F Hernández
Journal:  Int Ophthalmol       Date:  2014-07-31       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.